GentaDug 85 mg/ml solution for injection for horses, cattle, pigs, dogs and cats

Valsts: Īrija

Valoda: angļu

Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)

Aktīvā sastāvdaļa:

Gentamicin sulfate

Pieejams no:

Bela-Pharm GmbH & Co. KG

ATĶ kods:

QJ01GB03

SNN (starptautisko nepatentēto nosaukumu):

Gentamicin sulfate

Zāļu forma:

Solution for injection

Receptes veids:

POM: Prescription Only Medicine as defined in relevant national legislation

Ārstniecības joma:

gentamicin

Autorizācija datums:

2023-08-04

Produkta apraksts

1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
GentaDug 85 mg/ml solution for injection for horses, cattle, pigs,
dogs and cats.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1.0 ml solution for injection contains:
ACTIVE SUBSTANCE:
Gentamicin sulphate
85 mg
(equivalent to Gentamicin
50 mg)
QUALITATIVE
COMPOSITION OF EXCIPIENTS AND
OTHER CONSTITUENTS
QUANTITATIVE
COMPOSITION
IF THAT INFORMATION
IS ESSENTIAL
FOR PROPER ADMINISTRATION OF THE
VETERINARY MEDICINAL PRODUC
t
_ _
Methyl parahydroxybenzoate
0.9 mg
Propyl parahydroxybenzoate
0.1 mg
Sodium metabisulfite
Water for injection
A clear, colourless to slight yellow solution.
3.
CLINICAL INFORMATION
3.1
TARGET SPECIES
Horses (non-food producing horses), cattle, pigs, dogs and cats.
3.2
INDICATIONS FOR USE FOR EACH TARGET SPECIES
Treatment of the following infections:
Horses: for the treatment of infections of the lower respiratory tract
in horses caused by aerobic Gram-
negative bacteria.
Cattle: infections of the genital tract.
Calves: infections of the respiratory tract, infections of the
gastro-intestinal tract, septicaemia,
infections of the joints, infections of the auditory meatus.
Pigs: infections of the respiratory tract, metritis, mastitis and
agalactia (MMA) complex.
Piglets, weaners: infections of the respiratory tract, enzootic
pneumonia, infections caused by
_E. coli_
.
Dogs, cats: infections of the respiratory tract, infections of the
gastro-intestinal tract, infections of the
kidneys, the urinary and the genital tract, septicaemia, infections of
the auditory meatus.
3.3
CONTRAINDICATIONS
Do not use in animals with impaired renal function.
Do not use in dehydrated animals due to the risk of acute renal
failure.
Do not use in animals with disturbances of the vestibular or auditory
systems.
Do not use in cases of known hypersensitivity to the active substance
or to any of the excipients.
Do not inject intravenously if used concomitantly with muscle
relaxants.
Do not use concomitantly with bacteriostatic antibiotics.
Do not administer concurrently with diur